Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

New research suggests that balance and coordination problems in multiple sclerosis may begin when key brain cells slowly run ...

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...